Position in NVCR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,057,218
+$727,985 QoQ
Shares Held
135,790
+11.4% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 217 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,271,214,892 across 85 Medical Devices names. NVCR ranks #36 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,820,543 | $255,936,071 | |
| 2 | SYK |
Stryker Corp
|
616,745 | $194,175,995 | |
| 3 | MDT |
Medtronic plc
|
2,213,044 | $173,126,432 | |
| 4 | BSX |
Boston Scientific Corp
|
2,641,843 | $112,753,859 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,096,770 | $99,213,814 | |
| 6 | DXCM |
Dexcom Inc
|
768,165 | $51,735,912 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
755,006 | $48,327,934 | |
| 8 | STE |
STERIS plc
|
217,541 | $45,807,608 |
All Filings in NVCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,057,218 | 135,790 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,329,233 | 121,948 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,615,732 | 124,960 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,903,283 | 147,313 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,718,932 | 152,749 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,689,964 | 150,952 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $4,334,976 | 145,469 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,224,993 | 142,354 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,571,538 | 150,119 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,762,360 | 112,755 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,877,074 | 125,725 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,051,453 | 127,025 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,524,355 | 133,117 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $7,082,326 | 117,764 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,725,075 | 105,318 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,820,241 | 102,925 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,754,705 | 97,190 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,266,690 | 87,709 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,355,062 | 97,963 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $10,929,970 | 94,086 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $20,998,146 | 94,663 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $13,016,293 | 98,474 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $18,079,911 | 104,484 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $11,778,267 | 105,815 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,654,942 | 112,225 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,174,739 | 121,395 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||